Abbott Laboratories reported Q4 2025 sales of $11.46 billion, an increase of 4.4% from the previous year but falling short of analyst projections by approximately 3%. The adjusted EPS was $1.50, ...
Caution on Confluent due to perceived significant growth rate slowdown. Challenges include unexpected shifts in consumption patterns, macroeconomic uncertainties, and potential talent retention issues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback